BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid

Reuters

2025/03/29

March 28 (Reuters) - bluebird bio Inc BLUE.O:

BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID
RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE
AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES
BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS
NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL

Source text: ID:nBwb6Pg2da

Further company coverage: BLUE.O

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2523663851"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2523663851\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2523663851?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-29 04:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2523663851","market":"us","top_or_hot":-1,"title":"BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid</title></head><body><p><span>March 28 (Reuters)</span><span> - </span>bluebird bio Inc <span>BLUE.O</span>:</p><ul><li><p>BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID</p></li><li><p>RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE</p></li><li><p>AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES</p></li><li><p>BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS</p></li><li><p>NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL</p></li></ul><p>Source text: <span>ID:nBwb6Pg2da</span></p><p>Further company coverage: <span>BLUE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-29 04:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid</title></head><body><p><span>March 28 (Reuters)</span><span> - </span>bluebird bio Inc <span>BLUE.O</span>:</p><ul><li><p>BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID</p></li><li><p>RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE</p></li><li><p>AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES</p></li><li><p>BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS</p></li><li><p>NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL</p></li></ul><p>Source text: <span>ID:nBwb6Pg2da</span></p><p>Further company coverage: <span>BLUE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA5QK0RN:1","article_id":"2523663851","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2523663851","pubTimestamp":1743193457,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From AyrmidMarch 28 (Reuters) - bluebird bio Inc BLUE.O:BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4556":"基因编辑","BK4578":"CAR-T"},"translate_title":"简介-Bluebird Bio确认收到Ayrmid主动提出的不具约束力的提案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLUE":0.9},"content_text":"BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From AyrmidMarch 28 (Reuters) - bluebird bio Inc BLUE.O:BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMIDRECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHAREAYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVESBOARD REVIEWING AYRMID PROPOSAL WITH ADVISORSNOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEALSource text: ID:nBwb6Pg2daFurther company coverage: BLUE.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}